The Thompson Family Foundation Initiative in CIPN & Sensory Neuroscience (TFFI) aims to leverage the extraordinary scope and depth of Columbia University's neuroscience community to attack CIPN.
This partnership between the Thompson Family Foundation and Columbia University provides a common vision, resources, and structure to engage in high-impact, novel research programs in neuropathic pain and pain biology. It will also provide the fundamentals to clinically assess disorders of the nervous system, to evaluate disease risk at the earliest stage, and to employ tools to develop and test strategies for early intervention. We anticipate that the translational research model outlined in this partnership will have broad scientific and public impact, and will emerge as a pioneering enterprise among leading academic institutions.
Why Columbia University?
At Columbia University Medical Center (CUMC), the Departments of Neurology, Neuroscience, Oncology, Pathology & Cell Biology, Physiology & Cellular Biophysics, and Dermatology, together with The Herbert Irving Comprehensive Cancer Center (HICCC), the Columbia Stem Cell Initiative, Irving Institute for Clinical and Translational Research (IICTR), the Center for Motor Neuron Biology and Disease (MNC), and the Zuckerman Mind Brain Behavior Institute (ZMBBI) on the Manhattanville campus, have created an alliance of collaborative basic, clinical, and translational research that is truly unparalleled among neuroscience programs worldwide. This alliance is housed in and administered by the unique, multidisciplinary Columbia Translational Neuroscience Initiative (CTNI).